<DOC>
	<DOC>NCT00309062</DOC>
	<brief_summary>Safety and efficacy of recombinant birch pollen allergen in the treatment of allergic rhinoconjunctivitis</brief_summary>
	<brief_title>Safety and Efficacy of Recombinant Birch Pollen Allergen in the Treatment of Allergic Rhinoconjunctivitis</brief_title>
	<detailed_description />
	<mesh_term>Rhinitis, Allergic, Seasonal</mesh_term>
	<criteria>Positive Skin Prick Test reaction to birch pollen Positive RAST result to birch pollen Positive Provocation Test result to birch pollen Serious chronic diseases Other perennial allergies</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>March 2013</verification_date>
	<keyword>Allergy</keyword>
	<keyword>Birch pollen</keyword>
	<keyword>Recombinant</keyword>
</DOC>